文献速递肝病

非酒精性脂肪性肝病中氨基酸浓度的改变:肥胖与胰岛素抵抗的影响

Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance.
PubMed 文献 · Hepatology · 2017-11-17

本研究纳入44例经肝活检的非糖尿病NAFLD患者(29例无肥胖、15例肥胖)及20例无肥胖对照,用气相色谱-质谱检测氨基酸谱。多数氨基酸仅在肥胖NAFLD者升高;谷氨酸、丝氨酸、甘氨酸指数(GSG指数)与肝脏胰岛素抵抗相关,且GSG指数可区分纤维化F3-4与F0-2。

要点

  • 多数氨基酸升高主要见于肥胖合并NAFLD者,非肥胖NAFLD者仅丙氨酸、谷氨酸、异亮氨酸和缬氨酸升高。
  • GSG指数与γ-谷氨酰转移酶相关(R=0.70),且不依赖体质指数。
  • GSG指数可区分纤维化F3-4与F0-2,可能作为肝病严重程度的标志物。

核心结论

  • 血浆氨基酸浓度升高主要见于肥胖且患NAFLD者,可能继发于胰岛素抵抗增加和蛋白质分解代谢增强。
  • GSG指数可能是独立于体质指数的肝病严重程度标志物。

研究设计与样本

  • 研究纳入44例无糖尿病的NAFLD患者(29例无肥胖、15例肥胖)和20例无肥胖对照,均经肝活检,采用气相色谱-质谱检测氨基酸谱。

主要发现

  • 多数氨基酸仅在肥胖NAFLD者中升高;非肥胖NAFLD者仅丙氨酸、谷氨酸、异亮氨酸和缬氨酸较对照升高,亮氨酸未升高。
  • 谷氨酸、酪氨酸和GSG指数与肝脏胰岛素抵抗相关。
  • GSG指数与肝酶相关,尤其与γ-谷氨酰转移酶相关(R=0.70),且独立于体质指数。
  • 肝活检气球样变和/或炎症与血浆支链氨基酸和芳香族氨基酸升高相关,并与GSG指数轻度相关。
  • 在本队列中,仅GSG指数能区分纤维化F3-4与F0-2。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Plasma concentrations of amino acids (AAs), in particular, branched chain AAs (BCAAs), are often found increased in nonalcoholic fatty liver disease (NAFLD); however, if this is due to increased muscular protein catabolism, obesity, and/or increased insulin resistance (IR) or impaired tissue metabolism is unknown. Thus, we evaluated a) if subjects with NAFLD without obesity (NAFLD-NO) compared to those with obesity (NAFLD-Ob) display altered plasma AAs compared to controls (CTs); and b) if AA concentrations are associated with IR and liver histology. Glutamic acid, serine, and glycine concentrations are known to be altered in NAFLD. Because these AAs are involved in glutathione synthesis, we hypothesized they might be related to the severity of NAFLD. We therefore measured the AA profile of 44 subjects with NAFLD without diabetes and who had a liver biopsy (29 NAFLD-NO and 15 NAFLD-Ob) and 20 CTs without obesity, by gas chromatography-mass spectrometry, homeostasis model assessment of insulin resistance, hepatic IR (Hep-IR; Hep-IR = endogenous glucose production × insulin), and the new glutamate-serine-glycine (GSG) index (glutamate/[serine + glycine]) and tested for an association with liver histology. Most AAs were increased only in NAFLD-Ob subjects. Only alanine, glutamate, isoleucine, and valine, but not leucine, were increased in NAFLD-NO subjects compared to CTs. Glutamate, tyrosine, and the GSG-index were correlated with Hep-IR. The GSG-index correlated with liver enzymes, in particular, gamma-glutamyltransferase (R = 0.70), independent of body mass index. Ballooning and/or inflammation at liver biopsy were associated with increased plasma BCAAs and aromatic AAs and were mildly associated with the GSG-index, while only the new GSG-index was able to discriminate fibrosis F3-4 from F0-2 in this cohort. CONCLUSION: Increased plasma AA concentrations were observed mainly in subjects with obesity and NAFLD, likely as a consequence of increased IR and protein catabolism. The GSG-index is a possible marker of severity of liver disease independent of body mass index. (Hepatology 2018;67:145-158).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Gaggini M, Carli F, Rosso C, et al. Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance. Hepatology. 2017. PMID: 28802074. doi:10.1002/hep.29465

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。